Immune thrombocytopenia (ITP) is mediated by platelet autoantibodies that accelerate
platelet destruction and inhibit their production. Most cases are considered idiopathic …

Immune thrombocytopaenic purpura (ITP) is an autoimmune bleeding disease that is rarely
fatal. However, in many adults treatment is unsatisfactory, with as much morbidity from the …

Children with immune thrombocytopenia (ITP) rarely suffer from life-threatening bleeds (eg,
intracranial hemorrhage). In such settings, the combination of IV methylprednisolone (IVMP) …

Immune thrombocytopenia (ITP) is an autoantibody-mediated bleeding disorder with both
accelerated platelet destruction and impaired platelet production. We and others have …

Derangement of cellular immunity is central in the pathophysiology of adult
autoimmune/idiopathic thrombocytopenic purpura (ITP). Herein we investigated cytokine …

Initially used as a replacement therapy for immunodeficiency diseases, intravenous
immunoglobulin (IVIg) is now widely used for a number of autoimmune and inflammatory …

The current outbreak of viral pneumonia, caused by novel coronavirus SARS-CoV-2, is the
focus of worldwide attention. The WHO declared the COVID-19 outbreak a pandemic event …

Immune thrombocytopenia (ITP) is a bleeding disorder characterized by antibody-opsonized
platelets being prematurely destroyed in the spleen, although some patients with ITP may …

Objectives: Investigate the contribution and mechanism of cell‐mediated cytotoxicity to the
pathogenesis of idiopathic thrombocytopenic purpura (ITP). Methods: We observed the …

Intravenous immunoglobulin (IVIg) is therapeutically used in a variety of immune-mediated
diseases. The beneficial effects of IVIg in auto-antibody-mediated diseases can be …